NewsBenzinga앰프리우스 테크놀로지스, 2026회계연도 GAAP 주당순이익 0.07달러 이상 예상, 추정치 -0.08달러 상회; 2026회계연도 매출 1억 4,500만 달러 예상, 추정치 1억 4,064만 달러 상회 앰프리우스 테크놀로지스, 2026회계연도 GAAP 주당순이익 0.07달러 이상 예상, 추정치 -0.08달러 상회; 2026회계연도 매출 1억 4,500만 달러 예상, 추정치 1억 4,064만 달러 상회 Benzinga 2026.11.10 21:11 (GMT+0) Open on Benzinga Other news Global-E Online Stock Is Falling Wednesday: What's Going On? Grifols Presents New Real-World Evidence Data From AMBAR Program, Contributing To Ongoing Research Evaluating Use Of TPE With Albumin Replacement In Patients With Alzheimer’s Disease HC Wainwright & Co. Maintains Buy on LifeMD, Lowers Price Target to $6 Stifel Maintains Buy on Ecolab, Raises Price Target to $356 Stifel Upgrades Tandem Diabetes Care to Buy, Raises Price Target to $26 Immuneering Presents Preclinical Data Demonstrating Potential Of Atebimetinib; Phase 2 Results Include Long Survival And Outstanding Tolerability Profile In First-Line Pancreatic Cancer Patients
Grifols Presents New Real-World Evidence Data From AMBAR Program, Contributing To Ongoing Research Evaluating Use Of TPE With Albumin Replacement In Patients With Alzheimer’s Disease
Immuneering Presents Preclinical Data Demonstrating Potential Of Atebimetinib; Phase 2 Results Include Long Survival And Outstanding Tolerability Profile In First-Line Pancreatic Cancer Patients